Related Experiment Video
Updated: Jul 15, 2026
06:51
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Recombinant adeno-associated virus vector hybrids efficiently target different skeletal cells
1The Biomedical and Tissue Engineering Group, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR.
Summary
Choosing the right recombinant adeno-associated virus (rAAV) serotypes is key for gene therapy. Different rAAV serotypes show varying efficiencies in targeting specific cells like chondrocytes, osteoblasts, and stromal cells for craniofacial gene delivery.
Area of Science:
- Gene Therapy
- Molecular Biology
- Tissue Engineering
Background:
- Efficient and tissue-specific gene delivery is crucial for successful gene therapy.
- Recombinant adeno-associated virus (rAAV) vectors are promising tools for gene therapy applications.
Purpose of the Study:
- To evaluate the transduction efficiency of different rAAV serotypes in specific craniofacial cell types.
- To establish an efficient in vivo rAAV-mediated delivery system for craniofacial gene therapy.
Main Methods:
- In vitro evaluation of rAAV serotype transduction efficiency using rat condylar chondrocytes, UMR106 cell line, and bone marrow stromal cells (BMSCs).
- Quantification of transduction efficiency via fluorescence-activated cell sorting (FACS) and ELISA analysis for eGFP expression and VEGF secretion.
Main Results:
- All tested rAAV serotypes demonstrated infectivity and induced eGFP expression and VEGF secretion.
- rAAV2 showed superior transduction efficiency in rat chondrocytes.
- rAAV1 was most efficient in the UMR106 osteoblast-like cell line.
- rAAV5 exhibited the highest infection efficiency in BMSCs.
Conclusions:
- Different rAAV serotypes possess distinct transduction efficiencies for specific craniofacial cell types.
- Variations in receptor binding and transduction pathways contribute to the differential targeting capabilities of rAAV vectors in oral tissues.
- rAAV-based hybrids offer potential for targeted gene delivery in the craniofacial region.
